Perera Pin-Yu相关文献与解析，生知库 | 链接生命科学的每一步

Yokoyama, Seiji; Perera, Pin-Yu; Terawaki, Seigo; Watanabe, Nobumasa; Kaminuma, Osamu; Waldmann, Thomas A; Hiroi, Takachika; Perera, Liyanage P; Rezaei, Nima

发表日期：2021

文献求助收藏

Development of leading first-generation vaccines against SARS-CoV-2

针对SARS-CoV-2的领先第一代疫苗的研发

期刊:Microbes and Infection

影响因子:2.7

doi:10.1016/j.micinf.2021.104841

Perera, Pin-Yu; Perera, Liyanage P

SARS-CoV-2

发表日期：2021

文献求助收藏

Protective-antigen (PA) based anthrax vaccines confer protection against inhalation anthrax by precluding the establishment of a systemic infection

基于保护性抗原（PA）的炭疽疫苗通过阻止全身感染的发生，从而提供针对吸入性炭疽的保护。

期刊:Human Vaccines & Immunotherapeutics

影响因子:3.5

doi:10.4161/hv.25337

Merkel, Tod J; Perera, Pin-Yu; Lee, Gloria M; Verma, Anita; Hiroi, Toyoko; Yokote, Hiroyuki; Waldmann, Thomas A; Perera, Liyanage P

The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use

白细胞介素-15在炎症和感染免疫反应中的作用：对其治疗应用的启示

期刊:Microbes and Infection

影响因子:2.7

doi:10.1016/j.micinf.2011.10.006

Perera, Pin-Yu; Lichy, Jack H; Waldmann, Thomas A; Perera, Liyanage P

Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities

研发一种高效的基于牛痘病毒的双重疫苗，以对抗天花和炭疽这两种重要的生物恐怖袭击病原体。

期刊:Proceedings of the National Academy of Sciences of the United States of America

影响因子:9.1

doi:10.1073/pnas.1013083107

Merkel, Tod J; Perera, Pin-Yu; Kelly, Vanessa K; Verma, Anita; Llewellyn, Zara N; Waldmann, Thomas A; Mosca, Joseph D; Perera, Liyanage P

Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.

含有整合 IL-15 的天花疫苗在免疫缺陷小鼠体内表现出增强的病毒清除能力，并能为食蟹猴提供针对致命性猴痘攻击的长期保护

期刊:Vaccine

影响因子:3.5

doi:10.1016/j.vaccine.2010.08.008

Zielinski Rafal J, Smedley Jeremy V, Perera Pin-Yu, Silvera Peter M, Waldmann Thomas A, Capala Jacek, Perera Liyanage P

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis

化疗药物DMXAA能够强效且特异性地激活TBK1-IRF-3信号通路。

期刊:Journal of Experimental Medicine

影响因子:10.6

doi:10.1084/jem.20061845

Roberts, Zachary J; Goutagny, Nadege; Perera, Pin-Yu; Kato, Hiroki; Kumar, Himanshu; Kawai, Taro; Akira, Shizuo; Savan, Ram; van Echo, David; Fitzgerald, Katherine A; Young, Howard A; Ching, Lai-Ming; Vogel, Stefanie N

Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma-Progress and Challenges

非编码RNA疗法在治疗前列腺癌方面的进展与挑战

In Memoriam: Asghar Aghamohammadi (May 30, 1951–November 14, 2020)

悼念：阿斯加尔·阿格哈哈哈马迪（Asghar Aghamhammadi）（1951年5月30日至2020年11月14日）

Development of leading first-generation vaccines against SARS-CoV-2

针对SARS-CoV-2的领先第一代疫苗的研发

Protective-antigen (PA) based anthrax vaccines confer protection against inhalation anthrax by precluding the establishment of a systemic infection

基于保护性抗原（PA）的炭疽疫苗通过阻止全身感染的发生，从而提供针对吸入性炭疽的保护。

The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use

白细胞介素-15在炎症和感染免疫反应中的作用：对其治疗应用的启示

Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities

研发一种高效的基于牛痘病毒的双重疫苗，以对抗天花和炭疽这两种重要的生物恐怖袭击病原体。

Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.

含有整合 IL-15 的天花疫苗在免疫缺陷小鼠体内表现出增强的病毒清除能力，并能为食蟹猴提供针对致命性猴痘攻击的长期保护

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis

化疗药物DMXAA能够强效且特异性地激活TBK1-IRF-3信号通路。